首页 > 最新文献

The American journal of pediatric hematology/oncology最新文献

英文 中文
Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor. 严重先天性中性粒细胞减少症1例中细胞因子水平升高及髓系祖细胞对粒细胞集落刺激因子的异常反应。干细胞因子在体外的作用。
Pub Date : 2020-10-31 DOI: 10.52677/MPH.2020.10.16.167
T. Shitara, H. Ijima, S. Yugami, M. Sotomatu, Takayoshi Kuroume
PURPOSEThe cytokine levels and the in vitro granulopoiesis were studied to evaluate the mechanism of impaired granulopoiesis in severe congenital neutropenia (SCN).PATIENT AND METHODSThe patient was a 5-year-old boy with SCN. We assayed the colony-stimulating activity (CSA) produced by peripheral blood (PB) cells from the patient. The plasma levels of cytokines were measured using enzyme immunoassay. These included granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1 alpha (IL-1 alpha), IL-1 beta, IL-2, IL-3, IL-4, IL-6, and tumor necrosis factor-alpha. The effects of IL-3 and stem cell factor (SCF) on the proliferation of granulocyte-macrophage colony-forming cells (GM-CFCs) were studied.RESULTSCSA produced by PB cells from the patient was almost the same as in the healthy control. The level of endogenous G-CSF was elevated to 334 pg/ml, and GM-CSF, IL-2, IL-3, and IL-6 were slightly elevated. The numbers of GM-CFCs were markedly depressed in the presence of G-CSF alone and showed no increment on additional stimulation by IL-3. SCF in combination with G-CSF significantly augmented the proliferation of GM-CFCs.CONCLUSIONSThese findings suggest that some cytokines including G-CSF may be elevated in SCN patients and that CSF may play an important role in the pathogenesis of SCN.
目的通过观察细胞因子水平和体外粒细胞生成的变化,探讨重度先天性中性粒细胞减少症(SCN)粒细胞生成受损的机制。患者和方法患者为一名5岁的男孩,患有SCN。我们检测了患者外周血细胞产生的集落刺激活性(CSA)。采用酶免疫分析法测定血浆细胞因子水平。包括粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素1 α (IL-1 α)、IL-1 β、IL-2、IL-3、IL-4、IL-6和肿瘤坏死因子α。研究了IL-3和干细胞因子(SCF)对粒细胞-巨噬细胞集落形成细胞(GM-CFCs)增殖的影响。结果患者PB细胞产生的scsa与健康对照组基本相同。内源性G-CSF水平升高至334 pg/ml, GM-CSF、IL-2、IL-3、IL-6轻度升高。G-CSF单独存在时,GM-CFCs的数量明显下降,IL-3的额外刺激没有增加。SCF与G-CSF联合可显著增强gm - cfc的增殖。结论SCN患者中包括G-CSF在内的一些细胞因子可能升高,CSF可能在SCN的发病过程中起重要作用。
{"title":"Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.","authors":"T. Shitara, H. Ijima, S. Yugami, M. Sotomatu, Takayoshi Kuroume","doi":"10.52677/MPH.2020.10.16.167","DOIUrl":"https://doi.org/10.52677/MPH.2020.10.16.167","url":null,"abstract":"PURPOSE\u0000The cytokine levels and the in vitro granulopoiesis were studied to evaluate the mechanism of impaired granulopoiesis in severe congenital neutropenia (SCN).\u0000\u0000\u0000PATIENT AND METHODS\u0000The patient was a 5-year-old boy with SCN. We assayed the colony-stimulating activity (CSA) produced by peripheral blood (PB) cells from the patient. The plasma levels of cytokines were measured using enzyme immunoassay. These included granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1 alpha (IL-1 alpha), IL-1 beta, IL-2, IL-3, IL-4, IL-6, and tumor necrosis factor-alpha. The effects of IL-3 and stem cell factor (SCF) on the proliferation of granulocyte-macrophage colony-forming cells (GM-CFCs) were studied.\u0000\u0000\u0000RESULTS\u0000CSA produced by PB cells from the patient was almost the same as in the healthy control. The level of endogenous G-CSF was elevated to 334 pg/ml, and GM-CSF, IL-2, IL-3, and IL-6 were slightly elevated. The numbers of GM-CFCs were markedly depressed in the presence of G-CSF alone and showed no increment on additional stimulation by IL-3. SCF in combination with G-CSF significantly augmented the proliferation of GM-CFCs.\u0000\u0000\u0000CONCLUSIONS\u0000These findings suggest that some cytokines including G-CSF may be elevated in SCN patients and that CSF may play an important role in the pathogenesis of SCN.","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"46 1","pages":"167-72"},"PeriodicalIF":0.0,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77823189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Sphenoid sinus involvement in neuroblastoma. 神经母细胞瘤中蝶窦受累。
M Kohli-Kumar, J Barbosa, R E Harris

Purpose: Malignancy of the sphenoid sinus, especially metastatic involvement, is an extremely rare event at any age and is usually associated with a poor prognosis. We present a case of a 5-year-old boy who underwent allogenic bone marrow transplantation for stage IV neuroblastoma.

Patients and methods: Three years later, he presented with an isolated lesion, histologically proven to be neuroblastoma, in the sphenoid sinus.

Results: Partial excision of the tumor, followed by chemotherapy and radiotherapy, achieved a remission for 3 years.

目的:蝶窦恶性肿瘤,尤其是转移性受累,在任何年龄都是极其罕见的,通常伴有预后不良。我们报告一个5岁的男孩,他接受了异体骨髓移植治疗IV期神经母细胞瘤。患者和方法:三年后,他提出了一个孤立的病变,组织学证实为神经母细胞瘤,在蝶窦。结果:部分切除肿瘤,化疗和放疗,达到缓解3年。
{"title":"Sphenoid sinus involvement in neuroblastoma.","authors":"M Kohli-Kumar,&nbsp;J Barbosa,&nbsp;R E Harris","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Malignancy of the sphenoid sinus, especially metastatic involvement, is an extremely rare event at any age and is usually associated with a poor prognosis. We present a case of a 5-year-old boy who underwent allogenic bone marrow transplantation for stage IV neuroblastoma.</p><p><strong>Patients and methods: </strong>Three years later, he presented with an isolated lesion, histologically proven to be neuroblastoma, in the sphenoid sinus.</p><p><strong>Results: </strong>Partial excision of the tumor, followed by chemotherapy and radiotherapy, achieved a remission for 3 years.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"377-9"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl. 短暂性狼疮抗凝血剂与凝血酶原缺乏:出血的不寻常原因在一个5岁的女孩。
J E Humphries, M N Acker, J E Pinkston, S Ruddy

Purpose: We present the association of a lupus anticoagulant with hypoprothrombinemia in a 5-year-old girl, who presented with ecchymoses and a hematoma. This coagulopathy should be included in the differential of bleeding in the previously healthy children.

Patients and methods: Coagulation and immunology laboratory evaluation was performed at the time of presentation with bleeding and 2 months later, after complete clinical recovery.

Results: A 5-year-old girl presented with ecchymoses and a hematoma after after an upper respiratory illness. Laboratory evaluation showed prolongation of both the prothrombin time (PT) and activated partial thromboplastin time (aPTT) due to the presence of a strong lupus anticoagulant associated with a decreased level of prothrombin (15 U/dl). Hypocomplementemia was also detected. Bruising resolved spontaneously, and the PT and aPTT gradually normalized. Reevaluation 2 months later showed that the lupus anticoagulant had disappeared and the prothrombin deficiency was markedly improved.

Conclusions: This case demonstrates that transient lupus anticoagulants must be included in the differential for bleeding in young children. Also, in children with lupus anticoagulants, neither the association of hypoprothrombinemia nor the presence of evidence of activation of the immune system appears to predict whether a patient will have or develop systemic lupus erythematosus.

目的:我们提出狼疮抗凝血剂与低凝血酶原血症的关联在一个5岁的女孩,谁提出了淤血和血肿。这种凝血功能障碍应包括在先前健康儿童出血的鉴别中。患者和方法:在出现出血时和临床完全恢复后2个月进行凝血和免疫学实验室评估。结果:一名5岁女孩在上呼吸道疾病后出现瘀斑和血肿。实验室评估显示凝血酶原时间(PT)和活化的部分凝血活酶时间(aPTT)的延长,由于存在与凝血酶原水平降低(15 U/dl)相关的强狼疮抗凝剂。还检测到补体不足。瘀伤自行消退,PT和aPTT逐渐恢复正常。2个月后复查显示狼疮抗凝剂消失,凝血酶原缺乏明显改善。结论:本病例表明,短暂性狼疮抗凝剂必须包括在鉴别出血的幼儿。此外,在使用狼疮抗凝剂的儿童中,无论是低凝血酶原血症的相关性,还是存在免疫系统激活的证据,似乎都不能预测患者是否会患有或发展为系统性红斑狼疮。
{"title":"Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.","authors":"J E Humphries,&nbsp;M N Acker,&nbsp;J E Pinkston,&nbsp;S Ruddy","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>We present the association of a lupus anticoagulant with hypoprothrombinemia in a 5-year-old girl, who presented with ecchymoses and a hematoma. This coagulopathy should be included in the differential of bleeding in the previously healthy children.</p><p><strong>Patients and methods: </strong>Coagulation and immunology laboratory evaluation was performed at the time of presentation with bleeding and 2 months later, after complete clinical recovery.</p><p><strong>Results: </strong>A 5-year-old girl presented with ecchymoses and a hematoma after after an upper respiratory illness. Laboratory evaluation showed prolongation of both the prothrombin time (PT) and activated partial thromboplastin time (aPTT) due to the presence of a strong lupus anticoagulant associated with a decreased level of prothrombin (15 U/dl). Hypocomplementemia was also detected. Bruising resolved spontaneously, and the PT and aPTT gradually normalized. Reevaluation 2 months later showed that the lupus anticoagulant had disappeared and the prothrombin deficiency was markedly improved.</p><p><strong>Conclusions: </strong>This case demonstrates that transient lupus anticoagulants must be included in the differential for bleeding in young children. Also, in children with lupus anticoagulants, neither the association of hypoprothrombinemia nor the presence of evidence of activation of the immune system appears to predict whether a patient will have or develop systemic lupus erythematosus.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"372-6"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. 静脉注射环磷酰胺治疗复发性舌骨上颈面淋巴管瘤。
C Turner, S Gross

Purpose: Surgical resection of cervicofacial cystic hygromas and lymphangiomas rarely effects complete reduction because of severe anatomic restrictions.

Patients and methods: With prior knowledge of cyclophosphamide activity against lesions of this type, a formal trial of cyclophosphamide was initiated.

Results: Overall dose escalation therapy resulted in 50% reduction in mass without recurrence after cessation of therapy and with minimal and readily reversible toxicity.

Conclusions: The favorable responses to cyclophosphamide in this study suggest that a prospective randomized trial should be initiated. Certainly, children who have airway and/or esophageal compromise who have failed surgical therapies should be considered for cyclophosphamide treatment.

目的:由于严重的解剖限制,手术切除颈面部囊性湿疣和淋巴管瘤很少能完全复位。患者和方法:预先了解环磷酰胺对这种类型病变的活性,环磷酰胺的正式试验被启动。结果:总体剂量递增治疗导致肿块减少50%,停止治疗后无复发,毒性最小且易于逆转。结论:环磷酰胺在本研究中的良好反应表明应该启动一项前瞻性随机试验。当然,手术治疗失败的气道和/或食管受损的儿童应该考虑使用环磷酰胺治疗。
{"title":"Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide.","authors":"C Turner,&nbsp;S Gross","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Surgical resection of cervicofacial cystic hygromas and lymphangiomas rarely effects complete reduction because of severe anatomic restrictions.</p><p><strong>Patients and methods: </strong>With prior knowledge of cyclophosphamide activity against lesions of this type, a formal trial of cyclophosphamide was initiated.</p><p><strong>Results: </strong>Overall dose escalation therapy resulted in 50% reduction in mass without recurrence after cessation of therapy and with minimal and readily reversible toxicity.</p><p><strong>Conclusions: </strong>The favorable responses to cyclophosphamide in this study suggest that a prospective randomized trial should be initiated. Certainly, children who have airway and/or esophageal compromise who have failed surgical therapies should be considered for cyclophosphamide treatment.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"325-8"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18975383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. 异环酰胺在横纹肌肉瘤组间试验方案中对大体残留肿瘤患者的肾毒性研究。
B Raney, L G Ensign, J Foreman, F Khan, W Newton, J Ortega, A Ragab, M Wharam, E Wiener, H Maurer

Purpose: The purpose of this review is to characterize the nephrotoxicity noted in newly diagnosed patients under 21 years of age after treatment with ifosfamide-containing chemotherapy regimens and local irradiation for localized gross residual rhabdomyosarcoma or undifferentiated sarcoma.

Patients and methods: From 1987 to 1991, 194 previously untreated patients received vincristine and ifosfamide plus dactinomycin or etoposide for 1-2 years. Ifosfamide was given at 1.8 g/m2/day for 5 days with sodium mercaptoethane sulfonate, or 9 g/m2 of ifosfamide per course. The three-drug regimen was repeated every 3-4 weeks.

Results: Twenty-eight patients (14%) developed renal toxicity: 19 had renal tubular dysfunction (RTD) characterized by low serum phosphate (< or = 3 mg/dl) or bicarbonate (< 20 or = mEq/L) levels, five had decreased glomerular function (DGF), and four had both RTD and DGF. When nine or more courses of ifosfamide (> 72 g/m2) were given, children < 3 years of age had a higher incidence of RTD than did children > or = 3 years of age (34% versus 6%; p < 0.001). A similar age difference was observed even when eight or fewer courses (< or = 72 g/m2) were given (p = 0.03). A matched case-control comparison showed that renal abnormalities at diagnosis, chiefly hydronephrosis, also increased the risk of renal tubular injury by ifosfamide by a factor of 13 (p < 0.001). Patients with DGF tended to be older than those with RTD, and all but one received > 72 g/m2 of ifosfamide.

Conclusions: Patients who are < 3 years of age who receive more than eight courses (> 72 g/m2) of ifosfamide and who have a preexisting renal abnormality have an increased risk of RTD and DGF. The renal function of patients being considered for ifosfamide treatment must be carefully monitored. Ifosfamide should be avoided in patients with renal abnormalities at diagnosis unless the potential benefit clearly exceeds the risk of further renal impairment.

目的:本综述的目的是描述21岁以下新诊断的患者在接受含异环磷酰胺的化疗方案和局部照射治疗局限性大体残余横纹肌肉瘤或未分化肉瘤后所注意到的肾毒性。患者和方法:从1987年到1991年,194例未经治疗的患者接受长春新碱和异环磷酰胺联合放线菌素或依托泊苷治疗1-2年。异环磷酰胺以1.8 g/m2/天的剂量与巯基乙烷磺酸钠一起给予,连续5天,或每疗程9 g/m2的异环磷酰胺。三药联合治疗每3-4周重复一次。结果:28名患者(14%)出现肾毒性:19名患者有肾小管功能障碍(RTD),表现为低血清磷酸盐(<或= 3mg /dl)或碳酸氢盐(< 20或= mEq/L)水平,5名患者肾小球功能(DGF)下降,4名患者同时患有RTD和DGF。当给予9个或更多疗程的异环磷酰胺(> 72 g/m2)时,< 3岁儿童的RTD发生率高于>或= 3岁儿童(34%对6%;P < 0.001)。即使给予8个疗程或更少疗程(<或= 72 g/m2),也观察到类似的年龄差异(p = 0.03)。一项匹配的病例对照比较显示,诊断时的肾脏异常,主要是肾积水,也增加了异环磷酰胺肾小管损伤的风险,其倍数为13 (p < 0.001)。DGF患者往往比RTD患者年龄大,除1例外,其余患者均接受了> 72 g/m2的异环磷酰胺治疗。结论:年龄< 3岁且接受异环磷酰胺治疗超过8个疗程(> 72 g/m2)且既往存在肾脏异常的患者发生RTD和DGF的风险增加。考虑接受异环磷酰胺治疗的患者的肾功能必须仔细监测。诊断时肾脏异常的患者应避免使用异环磷酰胺,除非潜在的益处明显超过进一步肾脏损害的风险。
{"title":"Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor.","authors":"B Raney,&nbsp;L G Ensign,&nbsp;J Foreman,&nbsp;F Khan,&nbsp;W Newton,&nbsp;J Ortega,&nbsp;A Ragab,&nbsp;M Wharam,&nbsp;E Wiener,&nbsp;H Maurer","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this review is to characterize the nephrotoxicity noted in newly diagnosed patients under 21 years of age after treatment with ifosfamide-containing chemotherapy regimens and local irradiation for localized gross residual rhabdomyosarcoma or undifferentiated sarcoma.</p><p><strong>Patients and methods: </strong>From 1987 to 1991, 194 previously untreated patients received vincristine and ifosfamide plus dactinomycin or etoposide for 1-2 years. Ifosfamide was given at 1.8 g/m2/day for 5 days with sodium mercaptoethane sulfonate, or 9 g/m2 of ifosfamide per course. The three-drug regimen was repeated every 3-4 weeks.</p><p><strong>Results: </strong>Twenty-eight patients (14%) developed renal toxicity: 19 had renal tubular dysfunction (RTD) characterized by low serum phosphate (< or = 3 mg/dl) or bicarbonate (< 20 or = mEq/L) levels, five had decreased glomerular function (DGF), and four had both RTD and DGF. When nine or more courses of ifosfamide (> 72 g/m2) were given, children < 3 years of age had a higher incidence of RTD than did children > or = 3 years of age (34% versus 6%; p < 0.001). A similar age difference was observed even when eight or fewer courses (< or = 72 g/m2) were given (p = 0.03). A matched case-control comparison showed that renal abnormalities at diagnosis, chiefly hydronephrosis, also increased the risk of renal tubular injury by ifosfamide by a factor of 13 (p < 0.001). Patients with DGF tended to be older than those with RTD, and all but one received > 72 g/m2 of ifosfamide.</p><p><strong>Conclusions: </strong>Patients who are < 3 years of age who receive more than eight courses (> 72 g/m2) of ifosfamide and who have a preexisting renal abnormality have an increased risk of RTD and DGF. The renal function of patients being considered for ifosfamide treatment must be carefully monitored. Ifosfamide should be avoided in patients with renal abnormalities at diagnosis unless the potential benefit clearly exceeds the risk of further renal impairment.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"286-95"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal detection of neuroblastoma by fetal ultrasonography. 胎儿超声对神经母细胞瘤的产前检测。
R L Saylors, S L Cohn, E R Morgan, G M Brodeur

Purpose: We report three cases of neuroblastoma diagnosed by prenatal ultrasound examination and examine the biologic features of tumors diagnosed prenatally.

Patients and methods: Neuroblastoma is the most common tumor detected in the newborn period. Thus, some of these tumors develop prenatally and should be detectable by maternal ultrasound. Here we report three cases in which a neuroblastoma was suspected on prenatal ultrasonography. In addition, we review selected features of 17 additional cases reported in the literature.

Results and conclusions: These data indicate that, although the majority of patients have favorable clinical and biological features and do well, some patients do not, and the DNA index may be the most important predictor of outcome.

目的:报告3例经产前超声诊断为神经母细胞瘤的病例,探讨产前超声诊断的肿瘤的生物学特征。患者和方法:神经母细胞瘤是新生儿最常见的肿瘤。因此,这些肿瘤中有一些是在产前形成的,应该通过母体超声检测出来。我们在此报告三例产前超声检查怀疑为神经母细胞瘤的病例。此外,我们回顾了文献中报道的另外17例病例的选择特征。结果和结论:这些数据表明,尽管大多数患者具有良好的临床和生物学特征并且表现良好,但也有一些患者表现不佳,DNA指数可能是预后最重要的预测因素。
{"title":"Prenatal detection of neuroblastoma by fetal ultrasonography.","authors":"R L Saylors,&nbsp;S L Cohn,&nbsp;E R Morgan,&nbsp;G M Brodeur","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>We report three cases of neuroblastoma diagnosed by prenatal ultrasound examination and examine the biologic features of tumors diagnosed prenatally.</p><p><strong>Patients and methods: </strong>Neuroblastoma is the most common tumor detected in the newborn period. Thus, some of these tumors develop prenatally and should be detectable by maternal ultrasound. Here we report three cases in which a neuroblastoma was suspected on prenatal ultrasonography. In addition, we review selected features of 17 additional cases reported in the literature.</p><p><strong>Results and conclusions: </strong>These data indicate that, although the majority of patients have favorable clinical and biological features and do well, some patients do not, and the DNA index may be the most important predictor of outcome.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"356-60"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome. 播散性组织胞浆菌病:感染相关噬血细胞综合征的一种病因。
F G Keller, J Kurtzberg

Purpose: We report a case of infection-associated hemophagocytic syndrome in the setting of disseminated histoplasmosis.

Patients and methods: A 6-year-old boy with chronic mucocutaneous candidiasis developed a fulminant hemophagocytic syndrome. Evaluation for an infectious cause included bacterial, mycobacterial, viral, and fungal cultures, serological assessment, and histological examination of bone marrow and bronchoalveolar lavage fluid.

Results: Culture of bone marrow aspirate, blood, and bronchoalveolar lavage showed disseminated histoplasmosis as the cause for this patient's hemophagocytic syndrome. The patient was treated with amphotericin B with complete resolution of his hemophagocytic syndrome.

Conclusions: Disseminated histoplasmosis is another cause of IAHS in children with an underlying immunodeficiency. Diagnostic difficulties associated with the hemophagocytic syndromes of childhood are discussed.

目的:我们报告一例播散性组织胞浆菌病感染相关的噬血细胞综合征。患者和方法:一名患有慢性皮肤粘膜念珠菌病的6岁男孩出现暴发性噬血细胞综合征。感染原因的评估包括细菌、分枝杆菌、病毒和真菌培养、血清学评估以及骨髓和支气管肺泡灌洗液的组织学检查。结果:骨髓抽吸培养、血液培养和支气管肺泡灌洗显示弥散性组织胞浆菌病是该患者噬血细胞综合征的病因。患者经两性霉素B治疗后,其噬血细胞综合征完全消失。结论:播散性组织胞浆菌病是伴有潜在免疫缺陷的儿童发生IAHS的另一个原因。诊断困难与嗜血细胞综合征的儿童讨论。
{"title":"Disseminated histoplasmosis: a cause of infection-associated hemophagocytic syndrome.","authors":"F G Keller,&nbsp;J Kurtzberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>We report a case of infection-associated hemophagocytic syndrome in the setting of disseminated histoplasmosis.</p><p><strong>Patients and methods: </strong>A 6-year-old boy with chronic mucocutaneous candidiasis developed a fulminant hemophagocytic syndrome. Evaluation for an infectious cause included bacterial, mycobacterial, viral, and fungal cultures, serological assessment, and histological examination of bone marrow and bronchoalveolar lavage fluid.</p><p><strong>Results: </strong>Culture of bone marrow aspirate, blood, and bronchoalveolar lavage showed disseminated histoplasmosis as the cause for this patient's hemophagocytic syndrome. The patient was treated with amphotericin B with complete resolution of his hemophagocytic syndrome.</p><p><strong>Conclusions: </strong>Disseminated histoplasmosis is another cause of IAHS in children with an underlying immunodeficiency. Diagnostic difficulties associated with the hemophagocytic syndromes of childhood are discussed.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"368-71"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatitis associated with brain tumor therapy. 胰腺炎与脑肿瘤治疗相关。
D A Margolis, S L Werlin, K J Murray, D R Strother

Purpose: Four children with prolonged emesis during brain tumor therapy were diagnosed with pancreatitis.

Patients and methods: All were exposed to medications or radiotherapy that potentially contributed to pancreatitis.

Conclusions: Because recognition of pancreatitis may necessitate changes in supportive care, pancreatitis should be included in the differential diagnosis of vomiting in this population.

目的:对4例脑肿瘤治疗中出现持续呕吐的患儿进行诊断。患者和方法:所有患者均暴露于可能导致胰腺炎的药物或放疗。结论:由于胰腺炎的识别可能需要改变支持治疗,胰腺炎应纳入该人群呕吐的鉴别诊断。
{"title":"Pancreatitis associated with brain tumor therapy.","authors":"D A Margolis,&nbsp;S L Werlin,&nbsp;K J Murray,&nbsp;D R Strother","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Four children with prolonged emesis during brain tumor therapy were diagnosed with pancreatitis.</p><p><strong>Patients and methods: </strong>All were exposed to medications or radiotherapy that potentially contributed to pancreatitis.</p><p><strong>Conclusions: </strong>Because recognition of pancreatitis may necessitate changes in supportive care, pancreatitis should be included in the differential diagnosis of vomiting in this population.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"301-4"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18975374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human immunodeficiency virus infection presenting as pancytopenia in an infant. 人类免疫缺陷病毒感染,表现为婴儿全血细胞减少症。
J Sultan, S Gaur, L Sandhaus, L D Frenkel, L J Ettinger

Case report: A 14-month-old infant presented with pancytopenia and Mycobacterium avium intracellularae (MAI) as the initial manifestation of acquired immunodeficiency syndrome (AIDS).

Conclusion: Human immunodeficiency virus (HIV-1) infections should be considered in the differential diagnosis of infants and children with cytopenias.

病例报告:一个14个月大的婴儿以全血细胞减少症和细胞内鸟分枝杆菌(MAI)为获得性免疫缺陷综合征(艾滋病)的最初表现。结论:人类免疫缺陷病毒(HIV-1)感染在婴儿和儿童细胞减少症的鉴别诊断中应予以考虑。
{"title":"Human immunodeficiency virus infection presenting as pancytopenia in an infant.","authors":"J Sultan,&nbsp;S Gaur,&nbsp;L Sandhaus,&nbsp;L D Frenkel,&nbsp;L J Ettinger","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Case report: </strong>A 14-month-old infant presented with pancytopenia and Mycobacterium avium intracellularae (MAI) as the initial manifestation of acquired immunodeficiency syndrome (AIDS).</p><p><strong>Conclusion: </strong>Human immunodeficiency virus (HIV-1) infections should be considered in the differential diagnosis of infants and children with cytopenias.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"334-7"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18975385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postpheochromocytoma erythropoietin-dependent erythrocytosis. A postischemic mechanism? 嗜铬细胞瘤后红细胞生成素依赖性红细胞增多症。后化学机制?
M Bosio, G Barosi

Purpose: Erythropoietin-dependent pure erythrocytosis (EDPE) is a rare disorder caused by idiopathic hypererythropoietinemia. We describe a 13-year-old girl who developed an EDPE-like erythrocytosis after removal of an adrenal pheochromocytoma.

Patients and methods: As occurs in EDPE, this post-pheochromocytoma erythrocytosis was associated with a high serum erythropoietin (s-Epo) level that maintained physiological regulation.

Results: Phlebotomies produced a three- to sixfold increase of s-Epo, and a 6-week course of theophylline caused a decrease of both s-Epo and hemoglobin.

Conclusions: We hypothesize that the intense and prolonged pheochromocytoma-induced renal ischemia before surgery could be the cause of this unique case of erythrocytosis.

目的:促红细胞生成素依赖性纯红细胞增多症(EDPE)是一种罕见的由特发性高促红细胞生成素血症引起的疾病。我们描述了一个13岁的女孩谁发展了edpe样红细胞增生去除肾上腺嗜铬细胞瘤后。患者和方法:与EDPE一样,嗜铬细胞瘤后的红细胞增多与维持生理调节的高血清促红细胞生成素(s-Epo)水平有关。结果:放血使s-Epo升高3 ~ 6倍,6周的茶碱治疗使s-Epo和血红蛋白均降低。结论:我们推测手术前嗜铬细胞瘤引起的强烈和长期的肾缺血可能是导致这一独特病例的红细胞增多的原因。
{"title":"Postpheochromocytoma erythropoietin-dependent erythrocytosis. A postischemic mechanism?","authors":"M Bosio,&nbsp;G Barosi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Erythropoietin-dependent pure erythrocytosis (EDPE) is a rare disorder caused by idiopathic hypererythropoietinemia. We describe a 13-year-old girl who developed an EDPE-like erythrocytosis after removal of an adrenal pheochromocytoma.</p><p><strong>Patients and methods: </strong>As occurs in EDPE, this post-pheochromocytoma erythrocytosis was associated with a high serum erythropoietin (s-Epo) level that maintained physiological regulation.</p><p><strong>Results: </strong>Phlebotomies produced a three- to sixfold increase of s-Epo, and a 6-week course of theophylline caused a decrease of both s-Epo and hemoglobin.</p><p><strong>Conclusions: </strong>We hypothesize that the intense and prolonged pheochromocytoma-induced renal ischemia before surgery could be the cause of this unique case of erythrocytosis.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 4","pages":"365-7"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18973280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The American journal of pediatric hematology/oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1